drug
as of 2026-07-01Simvastatin
MeSH D019821
at a glance
small molecule
Pre-approval / investigational in the US
Developed by Pakistan Institute of Living and Learning
7 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
small molecule
Indications
Investigational (via trials)
SchizophreniaCardiovascular DiseaseBipolar DisorderSchizophreniform DisorderMental DisordersSchizophreniaDepressive Disorder, MajorMajor Depressive DisorderSerious Mental IllnessPsychosis NOSCardiovascular DiseasesBipolar DisorderPsychotic DisordersPsychosis Not Otherwise SpecifiedSchizoaffective Disorder
Trials
7
Fixed Dose Intervention Trial of New England Enhancing Survival in SMI Patients
NCT02188121Phase 4Completed
Simvastatin Addition for Patients With Recent-onset Schizophrenia
NCT01999309Phase 3Completed
Randomized Double Blind Placebo Control Study in Patients with Schizophrenia
NCT01602029Phase 2Completed
Add-on Simvastatin in Schizophrenia Trial
NCT00605995—Terminated
Cardio Risk of Acute Schizophrenia Olanzapine Duke
NCT00672464Phase 4Withdrawn
Role of Anti-Inflammatory Agents in Patients With Schizophrenia
NCT00929955Phase 1Completed
Comparison of Optimal Antipsychotic Treatments for Adults With Schizophrenia
NCT00802100Phase 4Completed
KOLs & investigators
7
Iris E.C. Sommer, Prof. Dr.KOL score 16
Prof Imran B Chaudhry, MDKOL score 5
T. Scott Stroup, MD, MPHKOL score 5
Joseph P. McEvoy, MDKOL score 4
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
trial
indication
indication
indication
indication
indication
KOL
Iris E.C. Sommer, Prof. Dr.
personKOL score 16
Prof Imran B Chaudhry, MD
personKOL score 5
T. Scott Stroup, MD, MPH
personKOL score 5
Joseph P. McEvoy, MD
personKOL score 4